Orient Electric Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 14, 2025, 9:19 pm

Quick Insight

Orient Electric Ltd currently trades at a price of 209 with a market capitalization of 4,469 Cr. The company's P/E stands at 51.7, reflecting a premium valuation in the domestic appliances industry. With an ROE of 12.5% and ROCE at 17.9%, Orient Electric demonstrates decent profitability and capital efficiency. The low OPM of 6% may warrant attention to operational efficiency. Notably, the company's borrowings amount to ₹86Cr against reserves of 673 Cr, indicating a healthy balance sheet. The diversified shareholding pattern, with promoters at 38.30%, FIIs at 7.09%, and DIIs at 27.86%, offers stability. Overall, Orient Electric's strong financial position and growth potential make it an intriguing investment opportunity in the domestic appliances sector.

Competitors of Orient Electric Ltd

All Competitor Stocks of Orient Electric Ltd

Quarterly Result

Last Updated: August 1, 2025, 4:05 pm

Below is a detailed analysis of the quarterly data for Orient Electric Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 769.00 Cr.. The value appears to be declining and may need further review. It has decreased from 862.00 Cr. (Mar 2025) to 769.00 Cr., marking a decrease of 93.00 Cr..
• For Expenses, as of Jun 2025, the value is 723.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 795.00 Cr. (Mar 2025) to 723.00 Cr., marking a decrease of 72.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 46.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Mar 2025) to 46.00 Cr., marking a decrease of 21.00 Cr..
• For OPM %, as of Jun 2025, the value is 6.00%. The value appears to be declining and may need further review. It has decreased from 8.00% (Mar 2025) to 6.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 5.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.00 Cr. (Mar 2025) to 5.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 19.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 22.00 Cr. (Mar 2025) to 19.00 Cr., marking a decrease of 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 42.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 18.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
• For Net Profit, as of Jun 2025, the value is 18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 31.00 Cr. (Mar 2025) to 18.00 Cr., marking a decrease of 13.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.82. The value appears to be declining and may need further review. It has decreased from 1.47 (Mar 2025) to 0.82, marking a decrease of 0.65.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:16 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 2:59 pm

Below is a detailed analysis of the balance sheet data for Orient Electric Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 21.00 Cr..
• For Reserves, as of Mar 2025, the value is 673.00 Cr.. The value appears strong and on an upward trend. It has increased from 618.00 Cr. (Mar 2024) to 673.00 Cr., marking an increase of 55.00 Cr..
• For Borrowings, as of Mar 2025, the value is 86.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 112.00 Cr. (Mar 2024) to 86.00 Cr., marking a decrease of 26.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 774.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 700.00 Cr. (Mar 2024) to 774.00 Cr., marking an increase of 74.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,555.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,451.00 Cr. (Mar 2024) to 1,555.00 Cr., marking an increase of 104.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 440.00 Cr.. The value appears strong and on an upward trend. It has increased from 236.00 Cr. (Mar 2024) to 440.00 Cr., marking an increase of 204.00 Cr..
• For CWIP, as of Mar 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 225.00 Cr. (Mar 2024) to 5.00 Cr., marking a decrease of 220.00 Cr..
• For Investments, as of Mar 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 37.00 Cr. (Mar 2024) to 14.00 Cr., marking a decrease of 23.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,096.00 Cr.. The value appears strong and on an upward trend. It has increased from 953.00 Cr. (Mar 2024) to 1,096.00 Cr., marking an increase of 143.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,555.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,451.00 Cr. (Mar 2024) to 1,555.00 Cr., marking an increase of 104.00 Cr..

Notably, the Reserves (673.00 Cr.) exceed the Borrowings (86.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Orient Electric Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 3.90. This value is below the healthy minimum of 5. It has increased from 3.53 (Mar 24) to 3.90, marking an increase of 0.37.
• For Diluted EPS (Rs.), as of Mar 25, the value is 3.90. This value is below the healthy minimum of 5. It has increased from 3.53 (Mar 24) to 3.90, marking an increase of 0.37.
• For Cash EPS (Rs.), as of Mar 25, the value is 7.60. This value is within the healthy range. It has increased from 6.29 (Mar 24) to 7.60, marking an increase of 1.31.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 32.54. It has increased from 29.94 (Mar 24) to 32.54, marking an increase of 2.60.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 32.54. It has increased from 29.94 (Mar 24) to 32.54, marking an increase of 2.60.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.50. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 144.97. It has increased from 131.78 (Mar 24) to 144.97, marking an increase of 13.19.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 10.10. This value is within the healthy range. It has increased from 7.49 (Mar 24) to 10.10, marking an increase of 2.61.
• For PBIT / Share (Rs.), as of Mar 25, the value is 6.40. This value is within the healthy range. It has increased from 4.73 (Mar 24) to 6.40, marking an increase of 1.67.
• For PBT / Share (Rs.), as of Mar 25, the value is 5.26. This value is within the healthy range. It has increased from 4.51 (Mar 24) to 5.26, marking an increase of 0.75.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 3.90. This value is within the healthy range. It has increased from 3.53 (Mar 24) to 3.90, marking an increase of 0.37.
• For PBDIT Margin (%), as of Mar 25, the value is 6.96. This value is below the healthy minimum of 10. It has increased from 5.68 (Mar 24) to 6.96, marking an increase of 1.28.
• For PBIT Margin (%), as of Mar 25, the value is 4.41. This value is below the healthy minimum of 10. It has increased from 3.58 (Mar 24) to 4.41, marking an increase of 0.83.
• For PBT Margin (%), as of Mar 25, the value is 3.62. This value is below the healthy minimum of 10. It has increased from 3.42 (Mar 24) to 3.62, marking an increase of 0.20.
• For Net Profit Margin (%), as of Mar 25, the value is 2.68. This value is below the healthy minimum of 5. It has increased from 2.67 (Mar 24) to 2.68, marking an increase of 0.01.
• For Return on Networth / Equity (%), as of Mar 25, the value is 11.98. This value is below the healthy minimum of 15. It has increased from 11.78 (Mar 24) to 11.98, marking an increase of 0.20.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.73. This value is within the healthy range. It has increased from 13.75 (Mar 24) to 17.73, marking an increase of 3.98.
• For Return On Assets (%), as of Mar 25, the value is 5.35. This value is within the healthy range. It has increased from 5.18 (Mar 24) to 5.35, marking an increase of 0.17.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.06. It has decreased from 2.07 (Mar 24) to 2.06, marking a decrease of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 1.33. This value is below the healthy minimum of 1.5. It has increased from 1.28 (Mar 24) to 1.33, marking an increase of 0.05.
• For Quick Ratio (X), as of Mar 25, the value is 0.78. This value is below the healthy minimum of 1. It has decreased from 0.84 (Mar 24) to 0.78, marking a decrease of 0.06.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.41. This value is below the healthy minimum of 4. It has decreased from 2.76 (Mar 24) to 2.41, marking a decrease of 0.35.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 42.51 (Mar 24) to 0.00, marking a decrease of 42.51.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 23.82 (Mar 24) to 0.00, marking a decrease of 23.82.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 57.49 (Mar 24) to 0.00, marking a decrease of 57.49.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 76.18 (Mar 24) to 0.00, marking a decrease of 76.18.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 8.90. This value is within the healthy range. It has increased from 6.87 (Mar 24) to 8.90, marking an increase of 2.03.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.43. This value is within the healthy range. It has increased from 3.43 (Mar 24) to 4.43, marking an increase of 1.00.
• For Enterprise Value (Cr.), as of Mar 25, the value is 4,426.59. It has increased from 4,071.03 (Mar 24) to 4,426.59, marking an increase of 355.56.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.43. This value is within the healthy range. It has decreased from 1.45 (Mar 24) to 1.43, marking a decrease of 0.02.
• For EV / EBITDA (X), as of Mar 25, the value is 20.54. This value exceeds the healthy maximum of 15. It has decreased from 25.47 (Mar 24) to 20.54, marking a decrease of 4.93.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.44. This value is within the healthy range. It has decreased from 1.46 (Mar 24) to 1.44, marking a decrease of 0.02.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 57.48 (Mar 24) to 0.00, marking a decrease of 57.48.
• For Price / BV (X), as of Mar 25, the value is 6.43. This value exceeds the healthy maximum of 3. It has decreased from 6.44 (Mar 24) to 6.43, marking a decrease of 0.01.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.44. This value is within the healthy range. It has decreased from 1.46 (Mar 24) to 1.44, marking a decrease of 0.02.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness